Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: CAMP4 Therapeutics(CAMP) the Revenue is 1.779 M (+18.84%), Miss estimate;the EBIT is -13.38 M (-2.7%), Beat estimate;the EPS is -0.58 (+6.45%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B18.84%
0.00B26.25%
-0.00B7.41%
EBITExceed expectations
-0.01B2.70%
-0.01B3.07%
+0.00B0.37%
EPSMiss expectations
-0.586.45%
-0.211165.96%
-0.368959.51%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf